Answers are grounded in this paper and cite their sources.
Introduction: Cerebral venous sinus thrombosis (CVST) presents with symptoms ranging from mild headaches to severe neurological issues, resulting in variable prognosis. This study assessed the effectiveness of the cerebral venous thrombosis grading scale (CVT-GS) in predicting short-term prognosis and recovery by comparing initial scores with 30-day modified Rankin Scale (mRS) outcomes, serving as an effective tool to predict the prognosis of the patient on presentation and in clinical judgement for it's management. Objective: This study evaluates the prognostic accuracy of the CVT-GS tool in predicting short-term outcomes in cerebral venous sinus thrombosis (CVST) patients. A diagnostic Methods: accuracy study was conducted at a tertiary care hospital in Pune, India, from June 2022 to January 2024. Seventy-four CVST patients confirmed via CT/MR venography were evaluated. The prognosis was predicted on day 1 using the CVTGS tool and compared with outcomes assessed using the mRS at 30 days. The mean age was 35.5 ± 12.5 years; males comprised 60.8%. The CVT-GS scores showed Results: a strong positive correlation with mRS outcomes (r = 0.594, p < 0.001). ROC analysis indicated an optimal CVT-GS cut-off of 4.5 for predicting mRS > 2, with an AUC of 0.897. Transverse sinus involvement (79.7%) was most common, followed by sigmoid sinus (66.2%). Haemorrhagic infarctions were noted in 35.1%, while parenchymal lesions were observed in 45.9% of cases. CVT-GS is a robust tool for predic Interpretation: ting outcomes in CVST patients. Regional validation highlights its utility in diverse populations and underscores the importance of early risk stratification.
No takes yet. Share an insight, caveat, or question.
Kannadka et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: